- Home
- Publications
- Publication Search
- Publication Details
Title
Huntington disease
Authors
Keywords
-
Journal
Nature Reviews Disease Primers
Volume -, Issue -, Pages 15005
Publisher
Springer Nature
Online
2015-04-21
DOI
10.1038/nrdp.2015.5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial
- (2015) LANCET NEUROLOGY
- Autophagy in Huntington disease and huntingtin in autophagy
- (2015) Dale D.O. Martin et al. TRENDS IN NEUROSCIENCES
- Mutant huntingtin is present in neuronal grafts in huntington disease patients
- (2014) Francesca Cicchetti et al. ANNALS OF NEUROLOGY
- HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFκB pathway dysregulation
- (2014) Ulrike Träger et al. BRAIN
- Silencing Mutant Huntingtin by Adeno-Associated Virus-Mediated RNA Interference Ameliorates Disease Manifestations in the YAC128 Mouse Model of Huntington's Disease
- (2014) Lisa M. Stanek et al. HUMAN GENE THERAPY
- A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease
- (2014) Marianne R. Smith et al. HUMAN MOLECULAR GENETICS
- A Novel Mutation of NKX2-1 Affecting 2 Generations With Hypothyroidism and Choreoathetosis
- (2014) Scott Williamson et al. JOURNAL OF CHILD NEUROLOGY
- Thinking about the end of life: a common issue for patients with Huntington’s disease
- (2014) Suzanne J. Booij et al. JOURNAL OF NEUROLOGY
- Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)
- (2014) Erik van Duijn et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- “Frontal” Behaviors Before the Diagnosis of Huntington’s Disease and Their Relationship to Markers of Disease Progression: Evidence of Early Lack of Awareness
- (2014) Kevin Duff et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study
- (2014) Victoria Gonzalez et al. JOURNAL OF NEUROSURGERY
- Chorea associated with Huntington's disease: To treat or not to treat?
- (2014) Joseph Jankovic et al. MOVEMENT DISORDERS
- Prospects for neuroprotective therapies in prodromal Huntington's disease
- (2014) Abhishek Chandra et al. MOVEMENT DISORDERS
- Diagnostic criteria for Huntington's disease based on natural history
- (2014) Ralf Reilmann et al. MOVEMENT DISORDERS
- Clinical trials in Huntington's disease: Interventions in early clinical development and newer methodological approaches
- (2014) Cristina Sampaio et al. MOVEMENT DISORDERS
- Targets for future clinical trials in Huntington's disease: What's in the pipeline?
- (2014) Edward J. Wild et al. MOVEMENT DISORDERS
- Current therapeutic options for Huntington's disease: Good clinical practice versus evidence-based approaches?
- (2014) Annie Killoran et al. MOVEMENT DISORDERS
- Genetic modifiers of Huntington's disease
- (2014) James F. Gusella et al. MOVEMENT DISORDERS
- The cognitive burden in Huntington's disease: Pathology, phenotype, and mechanisms of compensation
- (2014) Marina Papoutsi et al. MOVEMENT DISORDERS
- HD-CAB: A cognitive assessment battery for clinical trials in Huntington's disease1,2,3
- (2014) Julie C. Stout et al. MOVEMENT DISORDERS
- Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease
- (2014) Nan Wang et al. NATURE MEDICINE
- Transneuronal propagation of mutant huntingtin contributes to non–cell autonomous pathology in neurons
- (2014) Eline Pecho-Vrieseling et al. NATURE NEUROSCIENCE
- Huntington disease: natural history, biomarkers and prospects for therapeutics
- (2014) Christopher A. Ross et al. Nature Reviews Neurology
- White matter connectivity reflects clinical and cognitive status in Huntington's disease
- (2014) Govinda R. Poudel et al. NEUROBIOLOGY OF DISEASE
- PRECREST: A phase II prevention and biomarker trial of creatine in at-risk Huntington disease
- (2014) H. D. Rosas et al. NEUROLOGY
- Late-onset Huntington's disease: Diagnostic and prognostic considerations
- (2014) Georgios Koutsis et al. PARKINSONISM & RELATED DISORDERS
- A Monoclonal Antibody TrkB Receptor Agonist as a Potential Therapeutic for Huntington’s Disease
- (2014) Daniel Todd et al. PLoS One
- Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study
- (2014) Jane S. Paulsen et al. Frontiers in Aging Neuroscience
- Ubiquitin–proteasome system involvement in Huntington’s disease
- (2014) Zaira Ortega et al. Frontiers in Molecular Neuroscience
- High frequency of intermediate alleles on huntington disease-associated haplotypes in British Columbia's general population
- (2013) Alicia Semaka et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Membrane Interactions of the Amphipathic Amino Terminus of Huntingtin
- (2013) Matthias Michalek et al. BIOCHEMISTRY
- The uptake and outcome of prenatal and pre-implantation genetic diagnosis for Huntington's disease in the Netherlands (1998-2008)
- (2013) MC van Rij et al. CLINICAL GENETICS
- Evidence-based genetic counselling implications for Huntington disease intermediate allele predictive test results
- (2013) A. Semaka et al. CLINICAL GENETICS
- Experiences of predictive testing in young people at risk of Huntington’s disease, familial cardiomyopathy or hereditary breast and ovarian cancer
- (2013) Rhona MacLeod et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes
- (2013) Fiona K Baine et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- PGC-1α, mitochondrial dysfunction, and Huntington's disease
- (2013) Ashu Johri et al. FREE RADICAL BIOLOGY AND MEDICINE
- Linear and extended: a common polyglutamine conformation recognized by the three antibodies MW1, 1C2 and 3B5H10
- (2013) Fabrice A. C. Klein et al. HUMAN MOLECULAR GENETICS
- Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease
- (2013) M. Jiang et al. HUMAN MOLECULAR GENETICS
- Reproductive options for prospective parents in families with Huntington's disease: clinical, psychological and ethical reflections
- (2013) C. E. M. de Die-Smulders et al. HUMAN REPRODUCTION UPDATE
- Metabolic network as a progression biomarker of premanifest Huntington’s disease
- (2013) Chris C. Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease
- (2013) Alicia Semaka et al. JOURNAL OF MEDICAL GENETICS
- Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records
- (2013) Stephen JW Evans et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- MAP Kinase Phosphatase 1 (MKP-1/DUSP1) Is Neuroprotective in Huntington's Disease via Additive Effects of JNK and p38 Inhibition
- (2013) D. M. Taylor et al. JOURNAL OF NEUROSCIENCE
- A Small Molecule TrkB Ligand Reduces Motor Impairment and Neuropathology in R6/2 and BACHD Mouse Models of Huntington's Disease
- (2013) D. A. Simmons et al. JOURNAL OF NEUROSCIENCE
- An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
- (2013) Timothy M Miller et al. LANCET NEUROLOGY
- Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
- (2013) Sarah J Tabrizi et al. LANCET NEUROLOGY
- A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease
- (2013) MOVEMENT DISORDERS
- Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk
- (2013) Emily R. Fisher et al. MOVEMENT DISORDERS
- 8OHdG is not a biomarker for Huntington disease state or progression
- (2013) B. Borowsky et al. NEUROLOGY
- C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies
- (2013) D. J. Hensman Moss et al. NEUROLOGY
- Regulatory Innovation and Drug Development for Early-Stage Alzheimer's Disease
- (2013) Nicholas Kozauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exogenous delivery of chaperonin subunit fragment ApiCCT1 modulates mutant Huntingtin cellular phenotypes
- (2013) E. M. Sontag et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Polyglutamine domain flexibility mediates the proximity between flanking sequences in huntingtin
- (2013) Nicholas Stephane Caron et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
- (2013) K. Sathasivam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Huntington's disease: underlying molecular mechanisms and emerging concepts
- (2013) John Labbadia et al. TRENDS IN BIOCHEMICAL SCIENCES
- HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration
- (2013) Michal Mielcarek et al. PLOS BIOLOGY
- Mismatch Repair Genes Mlh1 and Mlh3 Modify CAG Instability in Huntington's Disease Mice: Genome-Wide and Candidate Approaches
- (2013) Ricardo Mouro Pinto et al. PLoS Genetics
- MSH3 Polymorphisms and Protein Levels Affect CAG Repeat Instability in Huntington's Disease Mice
- (2013) Stéphanie Tomé et al. PLoS Genetics
- Randomized Controlled Clinical Trial of “Virtual House Calls” for Parkinson Disease
- (2013) E. Ray Dorsey et al. JAMA Neurology
- Suppression of protein aggregation by chaperone modification of high molecular weight complexes
- (2012) John Labbadia et al. BRAIN
- Induced Pluripotent Stem Cells from Patients with Huntington's Disease Show CAG-Repeat-Expansion-Associated Phenotypes
- (2012) The HD iPSC Consortium Cell Stem Cell
- Providing predictive testing for Huntington disease via telehealth: results of a pilot study in British Columbia, Canada
- (2012) AK Hawkins et al. CLINICAL GENETICS
- The Future of Orphan Drug Development
- (2012) J Woodcock CLINICAL PHARMACOLOGY & THERAPEUTICS
- Validation of the first quality-of-life measurement for patients with Huntington’s disease
- (2012) Emilie Clay et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Mutant huntingtin fragmentation in immune cells tracks Huntington’s disease progression
- (2012) Andreas Weiss et al. JOURNAL OF CLINICAL INVESTIGATION
- Physical Chemistry of Polyglutamine: Intriguing Tales of a Monotonous Sequence
- (2012) Ronald Wetzel JOURNAL OF MOLECULAR BIOLOGY
- Health-related quality of life in Huntington’s disease patients: a comparison of proxy assessment and patient self-rating using the disease-specific Huntington’s disease health-related quality of life questionnaire (HDQoL)
- (2012) Mevhibe B. Hocaoglu et al. JOURNAL OF NEUROLOGY
- Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease
- (2012) Julie C Stout et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Longitudinal Evaluation of Neuropsychiatric Symptoms in Huntington's Disease
- (2012) Jennifer C. Thompson et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Prevalence estimates of Huntington disease in Caucasian populations are gross underestimates
- (2012) Patrick J. Morrison MOVEMENT DISORDERS
- The incidence and prevalence of Huntington's disease: A systematic review and meta-analysis
- (2012) Tamara Pringsheim et al. MOVEMENT DISORDERS
- Kynurenines in the CNS: recent advances and new questions
- (2012) László Vécsei et al. NATURE REVIEWS DRUG DISCOVERY
- Phosphodiesterase 10A (PDE10A) localization in the R6/2 mouse model of Huntington's disease
- (2012) Alessandro Leuti et al. NEUROBIOLOGY OF DISEASE
- CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
- (2012) J.- M. Lee et al. NEUROLOGY
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
- Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington’s disease
- (2012) J. Nithianantharajah et al. NEUROSCIENCE
- Genetic Knock-Down of Hdac3 Does Not Modify Disease-Related Phenotypes in a Mouse Model of Huntington's Disease
- (2012) Lara Moumné et al. PLoS One
- Fragments of HdhQ150 Mutant Huntingtin Form a Soluble Oligomer Pool That Declines with Aggregate Deposition upon Aging
- (2012) David Marcellin et al. PLoS One
- Msh2 Acts in Medium-Spiny Striatal Neurons as an Enhancer of CAG Instability and Mutant Huntingtin Phenotypes in Huntington’s Disease Knock-In Mice
- (2012) Marina Kovalenko et al. PLoS One
- Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice
- (2012) A. Di Pardo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice
- (2012) M. Garriga-Canut et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study
- (2012) Nicola Z. Hobbs et al. NeuroImage-Clinical
- Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease
- (2011) P. Hemachandra Reddy et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
- (2011) Daniel Zwilling et al. CELL
- Adverse childhood experiences of persons at risk for Huntington's disease or BRCA1/2 hereditary breast/ovarian cancer
- (2011) LB van der Meer et al. CLINICAL GENETICS
- The Huntington's Disease health-related Quality of Life questionnaire (HDQoL): a disease-specific measure of health-related quality of life
- (2011) MB Hocaoglu et al. CLINICAL GENETICS
- Regional Cerebral Glucose Metabolism After Pridopidine (ACR16) Treatment in Patients With Huntington Disease
- (2011) Mouna Esmaeilzadeh et al. CLINICAL NEUROPHARMACOLOGY
- Development of the HD-Teen Inventory
- (2011) Martha Driessnack et al. Clinical Nursing Research
- The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
- (2011) Susanna Campesan et al. CURRENT BIOLOGY
- Converging Pathways in the Occurrence of Endoplasmic Reticulum (ER) Stress in Huntingtons Disease
- (2011) R. Vidal et al. CURRENT MOLECULAR MEDICINE
- HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia
- (2011) Simon C Warby et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis
- (2011) Surya A. Reis et al. HUMAN MOLECULAR GENETICS
- Brain networks in Huntington disease
- (2011) David Eidelberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease
- (2011) John Labbadia et al. JOURNAL OF CLINICAL INVESTIGATION
- Slow Amyloid Nucleation via α-Helix-Rich Oligomeric Intermediates in Short Polyglutamine-Containing Huntingtin Fragments
- (2011) Murali Jayaraman et al. JOURNAL OF MOLECULAR BIOLOGY
- Promoting Excellence in End-of-Life Care
- (2011) Mary E. Dellefield et al. JOURNAL OF NEUROSCIENCE NURSING
- Development of biomarkers for Huntington's disease
- (2011) David W Weir et al. LANCET NEUROLOGY
- Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
- (2011) Justo Garcia de Yebenes et al. LANCET NEUROLOGY
- Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
- (2011) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin
- (2011) Jeffrey B Carroll et al. MOLECULAR THERAPY
- Factors contributing to institutionalization in patients with Huntington's disease
- (2011) Adam Rosenblatt et al. MOVEMENT DISORDERS
- Age, CAG repeat length, and clinical progression in Huntington's disease
- (2011) Adam Rosenblatt et al. MOVEMENT DISORDERS
- Assessment of involuntary choreatic movements in Huntington's disease-Toward objective and quantitative measures
- (2011) Ralf Reilmann et al. MOVEMENT DISORDERS
- Kinase inhibitors modulate huntingtin cell localization and toxicity
- (2011) Randy Singh Atwal et al. Nature Chemical Biology
- What have we learned from gene expression profiles in Huntington's disease?
- (2011) Tamara Seredenina et al. NEUROBIOLOGY OF DISEASE
- An evidence-based approach in the treatment of Huntington’s disease
- (2011) T.A. Mestre et al. PARKINSONISM & RELATED DISORDERS
- Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease
- (2011) Anna Bobrowska et al. PLoS One
- Episodic Memory in Dementia: Characteristics of New Learning that Differentiate Alzheimer's, Huntington's, and Parkinson's Diseases
- (2010) E. Aretouli et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- A Two-Step Path to Inclusion Formation of Huntingtin Peptides Revealed by Number and Brightness Analysis
- (2010) Giulia Ossato et al. BIOPHYSICAL JOURNAL
- Electrophysiological measures as potential biomarkers in Huntington's disease: Review and future directions
- (2010) Lan Nguyen et al. BRAIN RESEARCH REVIEWS
- Uptake of Huntington disease predictive testing in a complete population
- (2010) PJ Morrison et al. CLINICAL GENETICS
- Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease
- (2010) Christian Landles et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemical Inducers of Autophagy That Enhance the Clearance of Mutant Proteins in Neurodegenerative Diseases
- (2010) Maurizio Renna et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
- (2010) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Cognitive and functional decline in Huntington's disease: Dementia criteria revisited
- (2010) Guerry M. Peavy et al. MOVEMENT DISORDERS
- Grasping premanifest Huntington's disease - shaping new endpoints for new trials
- (2010) Ralf Reilmann et al. MOVEMENT DISORDERS
- Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease
- (2010) A. Sturrock et al. NEUROLOGY
- Neurocognitive signs in prodromal Huntington disease.
- (2010) Julie C. Stout et al. NEUROPSYCHOLOGY
- Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease
- (2010) Carmela Giampà et al. PLoS One
- CAG Expansion in the Huntington Disease Gene Is Associated with a Specific and Targetable Predisposing Haplogroup
- (2009) Simon C. Warby et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Single-step detection of mutant huntingtin in animal and human tissues: A bioassay for Huntington’s disease
- (2009) Andreas Weiss et al. ANALYTICAL BIOCHEMISTRY
- Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins
- (2009) Ferdinando Squitieri et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset
- (2009) Meera Swami et al. HUMAN MOLECULAR GENETICS
- Phosphorylation of Threonine 3
- (2009) Charity T. Aiken et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
- (2009) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates
- (2009) Pei-Hsien Ren et al. NATURE CELL BIOLOGY
- Complex brain networks: graph theoretical analysis of structural and functional systems
- (2009) Ed Bullmore et al. NATURE REVIEWS NEUROSCIENCE
- The chaperonin TRiC blocks a huntingtin sequence element that promotes the conformational switch to aggregation
- (2009) Stephen Tam et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism
- (2009) Ashwani K Thakur et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers
- (2009) Nicola Pavese et al. NEUROBIOLOGY OF DISEASE
- Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD Mice
- (2009) Xiaofeng Gu et al. NEURON
- Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease
- (2009) Caroline L. Benn et al. PLoS One
- Formation of Polyglutamine Inclusions in a Wide Range of Non-CNS Tissues in the HdhQ150 Knock-In Mouse Model of Huntington's Disease
- (2009) Hilary Moffitt et al. PLoS One
- Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease
- (2008) Valerio Leoni et al. BRAIN
- Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system — Evidence from event-related potentials
- (2008) Christian Beste et al. EXPERIMENTAL NEUROLOGY
- Immune markers for Huntington’s disease?
- (2008) Edward Wild et al. Expert Review of Neurotherapeutics
- Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons
- (2008) Diana Zala et al. HUMAN MOLECULAR GENETICS
- A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
- (2008) Maria Björkqvist et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Stimulus-Response Compatibility in Huntington's Disease: A Cognitive-Neurophysiological Analysis
- (2008) Christian Beste et al. JOURNAL OF NEUROPHYSIOLOGY
- Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation
- (2008) S. Threlfell et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Brain-specific Proteins Decline in the Cerebrospinal Fluid of Humans with Huntington Disease
- (2008) Qiaojun Fang et al. MOLECULAR & CELLULAR PROTEOMICS
- CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice
- (2008) Barbara L. Apostol et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Health-related quality of life in Huntington's disease: Which factors matter most?
- (2008) Aileen K. Ho et al. MOVEMENT DISORDERS
- Levels of brain related proteins in cerebrospinal fluid: An aid in the differential diagnosis of parkinsonian disorders
- (2008) Radu Constantinescu et al. PARKINSONISM & RELATED DISORDERS
- DNA instability in postmitotic neurons
- (2008) R. Gonitel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adapting Proteostasis for Disease Intervention
- (2008) William E. Balch et al. SCIENCE
- Detection of Huntington's disease decades before diagnosis: the Predict-HD study
- (2007) J S Paulsen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started